• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Roche`s Fenebrutinib Shows Promise In Multiple Sclerosis

    GLOBENEWSWIRE

    Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles

    BIOSPACE

    Genentech MS drug on partial US hold on liver enzyme elevations

    FIERCE BIOTECH

    Late-breaking data for Roche™s fenebrutinib show reduction in lesions

    GLOBENEWSWIRE

    Roche says new MS drug shown to reduce brain lesions

    REUTERS

    Genentech’s BTK Inhibitor Fenebrutinib Significantly Reduced Brain Lesions

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.